403 related articles for article (PubMed ID: 32060814)
61. Biodiversity and richness shifts of mucosa-associated gut microbiota with progression of colorectal cancer.
Pan HW; Du LT; Li W; Yang YM; Zhang Y; Wang CX
Res Microbiol; 2020; 171(3-4):107-114. PubMed ID: 31982498
[TBL] [Abstract][Full Text] [Related]
62. The human gut virome: form and function.
Ogilvie LA; Jones BV
Emerg Top Life Sci; 2017 Nov; 1(4):351-362. PubMed ID: 33525769
[TBL] [Abstract][Full Text] [Related]
63. Comparison of human gut microbiota in control subjects and patients with colorectal carcinoma in adenoma: Terminal restriction fragment length polymorphism and next-generation sequencing analyses.
Kasai C; Sugimoto K; Moritani I; Tanaka J; Oya Y; Inoue H; Tameda M; Shiraki K; Ito M; Takei Y; Takase K
Oncol Rep; 2016 Jan; 35(1):325-33. PubMed ID: 26549775
[TBL] [Abstract][Full Text] [Related]
64. Study Insights into Gastrointestinal Cancer through the Gut Microbiota.
Kong F; Cai Y
Biomed Res Int; 2019; 2019():8721503. PubMed ID: 31341907
[TBL] [Abstract][Full Text] [Related]
65. Integrated study of metabolomics and gut metabolic activity from ulcerative colitis to colorectal cancer: The combined action of disordered gut microbiota and linoleic acid metabolic pathway might fuel cancer.
Tang Q; Cang S; Jiao J; Rong W; Xu H; Bi K; Li Q; Liu R
J Chromatogr A; 2020 Oct; 1629():461503. PubMed ID: 32858455
[TBL] [Abstract][Full Text] [Related]
66. Stable core virome despite variable microbiome after fecal transfer.
Broecker F; Russo G; Klumpp J; Moelling K
Gut Microbes; 2017 May; 8(3):214-220. PubMed ID: 27935413
[TBL] [Abstract][Full Text] [Related]
67. Role of SCFAs in gut microbiome and glycolysis for colorectal cancer therapy.
Wang G; Yu Y; Wang YZ; Wang JJ; Guan R; Sun Y; Shi F; Gao J; Fu XL
J Cell Physiol; 2019 Aug; 234(10):17023-17049. PubMed ID: 30888065
[TBL] [Abstract][Full Text] [Related]
68. Analyzing the Secretome of Gut Microbiota as the Next Strategy For Early Detection of Colorectal Cancer.
Megat Mohd Azlan PI; Chin SF; Low TY; Neoh HM; Jamal R
Proteomics; 2019 May; 19(10):e1800176. PubMed ID: 30557447
[TBL] [Abstract][Full Text] [Related]
69. Bacterial driver-passenger model in biofilms: a new mechanism in the development of colorectal cancer.
Xing J; Fang Y; Zhang W; Zhang H; Tang D; Wang D
Clin Transl Oncol; 2022 May; 24(5):784-795. PubMed ID: 35000132
[TBL] [Abstract][Full Text] [Related]
70. The Dynamic Changes of Gut Microbiota in
Wu M; Wu Y; Li J; Bao Y; Guo Y; Yang W
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30231491
[TBL] [Abstract][Full Text] [Related]
71. Impact of bacterial infection and intestinal microbiome on colorectal cancer development.
Sun J
Chin Med J (Engl); 2022 Jan; 135(4):400-408. PubMed ID: 35089888
[TBL] [Abstract][Full Text] [Related]
72. Intestinal microorganisms involved in colorectal cancer complicated with dyslipidosis.
Han S; Pan Y; Yang X; Da M; Wei Q; Gao Y; Qi Q; Ru L
Cancer Biol Ther; 2019; 20(1):81-89. PubMed ID: 30239257
[TBL] [Abstract][Full Text] [Related]
73. Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer.
Coker OO; Nakatsu G; Dai RZ; Wu WKK; Wong SH; Ng SC; Chan FKL; Sung JJY; Yu J
Gut; 2019 Apr; 68(4):654-662. PubMed ID: 30472682
[TBL] [Abstract][Full Text] [Related]
74. Microbiome-driven carcinogenesis in colorectal cancer: Models and mechanisms.
Wang X; Yang Y; Huycke MM
Free Radic Biol Med; 2017 Apr; 105():3-15. PubMed ID: 27810411
[TBL] [Abstract][Full Text] [Related]
75. Gut microbiota-stimulated cathepsin K secretion mediates TLR4-dependent M2 macrophage polarization and promotes tumor metastasis in colorectal cancer.
Li R; Zhou R; Wang H; Li W; Pan M; Yao X; Zhan W; Yang S; Xu L; Ding Y; Zhao L
Cell Death Differ; 2019 Nov; 26(11):2447-2463. PubMed ID: 30850734
[TBL] [Abstract][Full Text] [Related]
76. Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice.
Wong SH; Zhao L; Zhang X; Nakatsu G; Han J; Xu W; Xiao X; Kwong TNY; Tsoi H; Wu WKK; Zeng B; Chan FKL; Sung JJY; Wei H; Yu J
Gastroenterology; 2017 Dec; 153(6):1621-1633.e6. PubMed ID: 28823860
[TBL] [Abstract][Full Text] [Related]
77. Systematic review: Gut microbiota in fecal samples and detection of colorectal neoplasms.
Amitay EL; Krilaviciute A; Brenner H
Gut Microbes; 2018 Jul; 9(4):293-307. PubMed ID: 29543545
[TBL] [Abstract][Full Text] [Related]
78. Role of intestinal microbiome in American ginseng-mediated colon cancer prevention in high fat diet-fed AOM/DSS mice [corrected].
Wang CZ; Huang WH; Zhang CF; Wan JY; Wang Y; Yu C; Williams S; He TC; Du W; Musch MW; Chang EB; Yuan CS
Clin Transl Oncol; 2018 Mar; 20(3):302-312. PubMed ID: 28808878
[TBL] [Abstract][Full Text] [Related]
79. The pediatric virome in health and disease.
Liang G; Gao H; Bushman FD
Cell Host Microbe; 2022 May; 30(5):639-649. PubMed ID: 35550667
[TBL] [Abstract][Full Text] [Related]
80. The Human Gut Virome Is Highly Diverse, Stable, and Individual Specific.
Shkoporov AN; Clooney AG; Sutton TDS; Ryan FJ; Daly KM; Nolan JA; McDonnell SA; Khokhlova EV; Draper LA; Forde A; Guerin E; Velayudhan V; Ross RP; Hill C
Cell Host Microbe; 2019 Oct; 26(4):527-541.e5. PubMed ID: 31600503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
